|
|
|
|
| LEADER |
01048caa a2200313 ir4500 |
| 001 |
NSK01000372675 |
| 003 |
HR-ZaNSK |
| 005 |
20080314074431.0 |
| 008 |
930326s1992 ci ||| ||eng |
| 015 |
|
|
|a HP92-4819
|2 HR
|
| 035 |
|
|
|9 (HR-ZaNSK)373120
|
| 035 |
|
|
|9 (HR-ZaNSK)930326069
|
| 035 |
|
|
|a (HR-ZaNSK)000372675
|
| 040 |
|
|
|a HR-ZaNSK
|b hrv
|c HR-ZaNSK
|e ppiak
|
| 041 |
0 |
|
|a eng
|b scr
|
| 080 |
|
|
|a 616.33-006-085
|
| 100 |
1 |
|
|a Roth, Anton
|
| 245 |
1 |
0 |
|a High of epirubicin and 5-fluorouracile in the treatment of advanced gastric cancer :
|b phase II study /
|c Anton Roth, Krsto Kolarić, Darko Županc, Andrej Roth, Josip Luetić.
|
| 300 |
|
|
|b Ilustr.
|
| 504 |
|
|
|a Bibliografija: 25 jed.
|
| 504 |
|
|
|a Sažetak
|
| 700 |
1 |
|
|a Kolarić, Krsto
|
| 700 |
1 |
|
|a Županc, Darko,
|c liječnik
|
| 700 |
1 |
|
|a Roth, Andrej
|
| 700 |
1 |
|
|a Luetić, Josip,
|c liječnik
|
| 773 |
0 |
|
|t Libri oncologici
|x 0300-8142
|g 21 (1992), 3 ; str. 173-177
|w nsk.(HR-ZaNSK)000011357
|
| 932 |
|
|
|a da
|b znanstveni rad
|
| 981 |
|
|
|p CRO
|
| 886 |
0 |
|
|2 unimarc
|b 00806naa2 2200229 450
|